HHS cancels funding for Moderna bird flu vaccine
Digest more
The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to phase out all petroleum-based synthetic dyes from food and drugs in the United States by the end of 2026.
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which vaccines to authorize or approve after being deemed safe and effective.
Pediatric and OB-GYN health care providers react to HHS Secretary Robert F. Kennedy Jr’s announcement on COVID-19 vaccine recommendations.
The US Department of Health and Human Services and US Food and Drug Administration have begun to comprehensively review the nutritional value of infant formula.
FDA and the Department of Health and Human Services (HHS) have launched a public Request for Information (RFI) to “identify and eliminate outdated or unnecessary regulations” in alignment with President Donald Trump’s Executive Order 14192.
9d
Tampa Free Press on MSNHHS, CMS Target “Most-Favored-Nation” Drug Pricing To Combat Global “Freeloading”The U.S. Department of Health and Human Services (HHS) today announced immediate steps to implement President Trump’s "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" Executive Order,
A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about 340B's future administration.
The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.
7don MSNOpinion
It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, however, the campaign expanded to include more wedges — the virus’ origins, school closures, mask mandates and, of course, vaccines.
According to Robert F. Kennedy Jr., David Geier was hired to review historical vaccine safety data, not to lead an autism-related study.